Robert Aspbury
Corporate Officer/Principal bij CERTARA, INC.
Vermogen: 5 M $ op 30-04-2024
Actieve functies van Robert Aspbury
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01-01-2020 | - |
Loopbaan van Robert Aspbury
Eerdere bekende functies van Robert Aspbury
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01-01-2003 | 01-03-2019 |
Opleiding van Robert Aspbury
| The University of Liverpool | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Technology Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Beurs
- Insiders
- Robert Aspbury
- Ervaring